

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 4.63312535 |
| 2 | plasma membrane repair (GO:0001778) | 4.38745139 |
| 3 | collagen fibril organization (GO:0030199) | 3.70602044 |
| 4 | basement membrane organization (GO:0071711) | 3.62966010 |
| 5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.59075523 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.58007130 |
| 7 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.56070987 |
| 8 | endothelial cell chemotaxis (GO:0035767) | 3.53071824 |
| 9 | protein retention in ER lumen (GO:0006621) | 3.51616390 |
| 10 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.47149237 |
| 11 | focal adhesion assembly (GO:0048041) | 3.45878743 |
| 12 | cell-substrate adherens junction assembly (GO:0007045) | 3.45878743 |
| 13 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.44055035 |
| 14 | regulation of histone H3-K27 methylation (GO:0061085) | 3.38614646 |
| 15 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.33813794 |
| 16 | vesicle coating (GO:0006901) | 3.31718379 |
| 17 | regulation of early endosome to late endosome transport (GO:2000641) | 3.27037001 |
| 18 | COPII vesicle coating (GO:0048208) | 3.23229669 |
| 19 | cell communication involved in cardiac conduction (GO:0086065) | 3.15539268 |
| 20 | protein heterotrimerization (GO:0070208) | 3.14700985 |
| 21 | sarcomere organization (GO:0045214) | 3.14163241 |
| 22 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.11834666 |
| 23 | cell communication by electrical coupling (GO:0010644) | 3.10933249 |
| 24 | sodium ion export (GO:0071436) | 3.09598321 |
| 25 | cardiac myofibril assembly (GO:0055003) | 3.08427859 |
| 26 | Golgi transport vesicle coating (GO:0048200) | 3.07614739 |
| 27 | COPI coating of Golgi vesicle (GO:0048205) | 3.07614739 |
| 28 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.04106625 |
| 29 | protein localization to endosome (GO:0036010) | 3.03507032 |
| 30 | activation of protein kinase A activity (GO:0034199) | 3.00704991 |
| 31 | regulation of extracellular matrix disassembly (GO:0010715) | 2.98959943 |
| 32 | semaphorin-plexin signaling pathway (GO:0071526) | 2.98469901 |
| 33 | negative regulation of cell size (GO:0045792) | 2.98405173 |
| 34 | carnitine shuttle (GO:0006853) | 2.92518238 |
| 35 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.90463323 |
| 36 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.82129914 |
| 37 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.81209336 |
| 38 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.80808661 |
| 39 | endodermal cell differentiation (GO:0035987) | 2.79158022 |
| 40 | regulation of ARF protein signal transduction (GO:0032012) | 2.76209260 |
| 41 | mannose metabolic process (GO:0006013) | 2.75829935 |
| 42 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.75671735 |
| 43 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.74486709 |
| 44 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.73850249 |
| 45 | atrioventricular valve morphogenesis (GO:0003181) | 2.72394922 |
| 46 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.72305840 |
| 47 | establishment of apical/basal cell polarity (GO:0035089) | 2.70569949 |
| 48 | iron ion import (GO:0097286) | 2.70091899 |
| 49 | cell adhesion mediated by integrin (GO:0033627) | 2.67667455 |
| 50 | collagen metabolic process (GO:0032963) | 2.67577250 |
| 51 | macroautophagy (GO:0016236) | 2.66668428 |
| 52 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.64985129 |
| 53 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.63898856 |
| 54 | fatty acid transmembrane transport (GO:1902001) | 2.63861044 |
| 55 | stress fiber assembly (GO:0043149) | 2.62987964 |
| 56 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.60762798 |
| 57 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.60369850 |
| 58 | regulation of p38MAPK cascade (GO:1900744) | 2.60072126 |
| 59 | myofibril assembly (GO:0030239) | 2.59270205 |
| 60 | collagen catabolic process (GO:0030574) | 2.58652543 |
| 61 | cardiac muscle contraction (GO:0060048) | 2.58053681 |
| 62 | protein targeting to Golgi (GO:0000042) | 2.57519817 |
| 63 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.53933925 |
| 64 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.53622236 |
| 65 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.52691706 |
| 66 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.52141053 |
| 67 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.51775125 |
| 68 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.51642169 |
| 69 | endocardial cushion development (GO:0003197) | 2.51085730 |
| 70 | positive regulation of nuclease activity (GO:0032075) | 2.50522454 |
| 71 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.50120214 |
| 72 | glomerular basement membrane development (GO:0032836) | 2.48715058 |
| 73 | bone trabecula formation (GO:0060346) | 2.48596995 |
| 74 | relaxation of cardiac muscle (GO:0055119) | 2.47350776 |
| 75 | regulation of fatty acid oxidation (GO:0046320) | 2.47164481 |
| 76 | establishment of protein localization to Golgi (GO:0072600) | 2.47128408 |
| 77 | cellular response to unfolded protein (GO:0034620) | 2.46312862 |
| 78 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.46111001 |
| 79 | cerebellar Purkinje cell layer development (GO:0021680) | 2.44060924 |
| 80 | layer formation in cerebral cortex (GO:0021819) | 2.43817177 |
| 81 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.43751997 |
| 82 | actomyosin structure organization (GO:0031032) | 2.42927095 |
| 83 | carnitine transmembrane transport (GO:1902603) | 2.42162959 |
| 84 | multicellular organismal metabolic process (GO:0044236) | 2.41486360 |
| 85 | potassium ion import (GO:0010107) | 2.41128566 |
| 86 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.40882565 |
| 87 | regulation of establishment of planar polarity (GO:0090175) | 2.40380466 |
| 88 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.39929867 |
| 89 | 4-hydroxyproline metabolic process (GO:0019471) | 2.39565096 |
| 90 | kidney mesenchyme development (GO:0072074) | 2.39563168 |
| 91 | multicellular organismal catabolic process (GO:0044243) | 2.39353788 |
| 92 | eye morphogenesis (GO:0048592) | 2.39179373 |
| 93 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.37621009 |
| 94 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.37473398 |
| 95 | synaptic vesicle maturation (GO:0016188) | 2.37366255 |
| 96 | embryonic eye morphogenesis (GO:0048048) | 2.36261413 |
| 97 | extracellular matrix disassembly (GO:0022617) | 2.36227665 |
| 98 | regulation of RNA export from nucleus (GO:0046831) | 2.35956293 |
| 99 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.35125731 |
| 100 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.34877272 |
| 101 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.34652977 |
| 102 | hemidesmosome assembly (GO:0031581) | 2.33616841 |
| 103 | apoptotic cell clearance (GO:0043277) | 2.33368183 |
| 104 | positive regulation of histone deacetylation (GO:0031065) | 2.32967513 |
| 105 | endocytic recycling (GO:0032456) | 2.32019772 |
| 106 | regulation of water loss via skin (GO:0033561) | 2.31740841 |
| 107 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.31201033 |
| 108 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.30995945 |
| 109 | regulation of synapse structural plasticity (GO:0051823) | 2.30356103 |
| 110 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.30293678 |
| 111 | cell-cell junction maintenance (GO:0045217) | 2.29520624 |
| 112 | endocrine hormone secretion (GO:0060986) | 2.29013758 |
| 113 | amino-acid betaine transport (GO:0015838) | 2.28757128 |
| 114 | carnitine transport (GO:0015879) | 2.28757128 |
| 115 | cell-substrate junction assembly (GO:0007044) | 2.28747915 |
| 116 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.28595721 |
| 117 | cellular response to topologically incorrect protein (GO:0035967) | 2.28249062 |
| 118 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.28226927 |
| 119 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.28035320 |
| 120 | positive regulation of p38MAPK cascade (GO:1900745) | 2.28013337 |
| 121 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.27951588 |
| 122 | metanephric mesenchyme development (GO:0072075) | 2.27474796 |
| 123 | growth hormone secretion (GO:0030252) | 2.27389871 |
| 124 | protein hydroxylation (GO:0018126) | 2.27173806 |
| 125 | regulation of membrane repolarization (GO:0060306) | 2.26678871 |
| 126 | camera-type eye morphogenesis (GO:0048593) | 2.25558408 |
| 127 | polarized epithelial cell differentiation (GO:0030859) | 2.25486846 |
| 128 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.25206985 |
| 129 | positive regulation of osteoblast proliferation (GO:0033690) | 2.24958836 |
| 130 | coronary vasculature morphogenesis (GO:0060977) | 2.24609767 |
| 131 | establishment of nucleus localization (GO:0040023) | 2.24585597 |
| 132 | protein targeting to plasma membrane (GO:0072661) | 2.24581896 |
| 133 | chondrocyte development (GO:0002063) | 2.22872786 |
| 134 | negative regulation of fatty acid transport (GO:2000192) | 2.21822401 |
| 135 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.21763265 |
| 136 | epithelial cell-cell adhesion (GO:0090136) | 2.21728358 |
| 137 | surfactant homeostasis (GO:0043129) | 2.20367478 |
| 138 | positive regulation of receptor recycling (GO:0001921) | 2.19878936 |
| 139 | regulation of cholesterol homeostasis (GO:2000188) | 2.18670809 |
| 140 | regulation of ARF GTPase activity (GO:0032312) | 2.18528309 |
| 141 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.18079895 |
| 142 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.17992270 |
| 143 | positive regulation of glycogen metabolic process (GO:0070875) | 2.17915601 |
| 144 | adherens junction assembly (GO:0034333) | 2.17846396 |
| 145 | peptidyl-lysine dimethylation (GO:0018027) | 2.17695157 |
| 146 | actin-myosin filament sliding (GO:0033275) | 2.16985074 |
| 147 | muscle filament sliding (GO:0030049) | 2.16985074 |
| 148 | peptidyl-proline hydroxylation (GO:0019511) | 2.16979791 |
| 149 | import into cell (GO:0098657) | 2.16765857 |
| 150 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.16453038 |
| 151 | low-density lipoprotein particle clearance (GO:0034383) | 2.16246748 |
| 152 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.15768082 |
| 153 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.15768082 |
| 154 | negative regulation of adherens junction organization (GO:1903392) | 2.15422509 |
| 155 | negative regulation of focal adhesion assembly (GO:0051895) | 2.15422509 |
| 156 | negative regulation of cell junction assembly (GO:1901889) | 2.15422509 |
| 157 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.15118292 |
| 158 | locomotory exploration behavior (GO:0035641) | 2.14728995 |
| 159 | regulation of nuclease activity (GO:0032069) | 2.14664146 |
| 160 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.14136333 |
| 161 | creatine metabolic process (GO:0006600) | 2.13539202 |
| 162 | positive regulation of fatty acid oxidation (GO:0046321) | 2.13430383 |
| 163 | negative regulation of potassium ion transport (GO:0043267) | 2.12847859 |
| 164 | skin morphogenesis (GO:0043589) | 2.11093829 |
| 165 | cellular potassium ion homeostasis (GO:0030007) | 2.10673803 |
| 166 | ER-nucleus signaling pathway (GO:0006984) | 2.10354209 |
| 167 | regulation of skeletal muscle contraction (GO:0014819) | 2.08569507 |
| 168 | positive regulation of fibroblast migration (GO:0010763) | 2.08227948 |
| 169 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.08199035 |
| 170 | 2-oxoglutarate metabolic process (GO:0006103) | 2.07779520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.20775178 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06515675 |
| 3 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.03937768 |
| 4 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.99703639 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.99567731 |
| 6 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.98989916 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.93340231 |
| 8 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.92526264 |
| 9 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.92016296 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.91529836 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.85038430 |
| 12 | KDM2B_26808549_Chip-Seq_K562_Human | 1.78266237 |
| 13 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.77061996 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.76213205 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.75733499 |
| 16 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.73496832 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.72594086 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.72159535 |
| 19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66407546 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.66227514 |
| 21 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.61223443 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.59069806 |
| 23 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.58099290 |
| 24 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.55218321 |
| 25 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.55218321 |
| 26 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.55160240 |
| 27 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.52718133 |
| 28 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.50550594 |
| 29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.49892302 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.49305287 |
| 31 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.49143754 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48137099 |
| 33 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.47516097 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.47127319 |
| 35 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.46369988 |
| 36 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.45960743 |
| 37 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.45663191 |
| 38 | ATF3_27146783_Chip-Seq_COLON_Human | 1.45519260 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.45482276 |
| 40 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44090141 |
| 41 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.43816524 |
| 42 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.43628278 |
| 43 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.40781736 |
| 44 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.40781736 |
| 45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40327019 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36801263 |
| 47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36573085 |
| 48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.34356242 |
| 49 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.32882963 |
| 50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.31870163 |
| 51 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.31255042 |
| 52 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.31255042 |
| 53 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.30875807 |
| 54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29996677 |
| 55 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.28067762 |
| 56 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27461644 |
| 57 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.27122445 |
| 58 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.26483059 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26019212 |
| 60 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.25628112 |
| 61 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25406236 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24444768 |
| 63 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.24403130 |
| 64 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.24088263 |
| 65 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.23769451 |
| 66 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.23700537 |
| 67 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23228316 |
| 68 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.23208628 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21709309 |
| 70 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.20112914 |
| 71 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.19840787 |
| 72 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.19681739 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19651187 |
| 74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19501357 |
| 75 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19082859 |
| 76 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18674067 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.18493826 |
| 78 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18377344 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.17129715 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16823748 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15781496 |
| 82 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15672866 |
| 83 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15287597 |
| 84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15145563 |
| 85 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.15048227 |
| 86 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14914685 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.14582983 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13172268 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12665833 |
| 90 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12145237 |
| 91 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.12066773 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12002811 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10904891 |
| 94 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09330629 |
| 95 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08311746 |
| 96 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.08124759 |
| 97 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.07772466 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07216776 |
| 99 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06703536 |
| 100 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06412644 |
| 101 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06154026 |
| 102 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05827451 |
| 103 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.05780247 |
| 104 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05235183 |
| 105 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.04981084 |
| 106 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04779842 |
| 107 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04773863 |
| 108 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04712883 |
| 109 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04187643 |
| 110 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03962666 |
| 111 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.03667874 |
| 112 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03254540 |
| 113 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.01559431 |
| 114 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.01306295 |
| 115 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00966012 |
| 116 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00077424 |
| 117 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99261570 |
| 118 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.98618850 |
| 119 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98609437 |
| 120 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98402341 |
| 121 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.96464809 |
| 122 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.95062721 |
| 123 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94965194 |
| 124 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94870708 |
| 125 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.93907655 |
| 126 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93859947 |
| 127 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92625537 |
| 128 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.91922331 |
| 129 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90949549 |
| 130 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89200615 |
| 131 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88872879 |
| 132 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88428006 |
| 133 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.88219556 |
| 134 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87901059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.28869175 |
| 2 | MP0000751_myopathy | 3.48852568 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.21336166 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.07530437 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.02089563 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 2.55141741 |
| 7 | MP0005275_abnormal_skin_tensile | 2.54833883 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.48472753 |
| 9 | MP0004130_abnormal_muscle_cell | 2.47050887 |
| 10 | MP0002909_abnormal_adrenal_gland | 2.42394078 |
| 11 | MP0004036_abnormal_muscle_relaxation | 2.40557128 |
| 12 | MP0005257_abnormal_intraocular_pressure | 2.23668614 |
| 13 | MP0005409_darkened_coat_color | 2.14317720 |
| 14 | MP0005451_abnormal_body_composition | 2.06697030 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.05982277 |
| 16 | MP0005623_abnormal_meninges_morphology | 2.03501968 |
| 17 | MP0004087_abnormal_muscle_fiber | 2.03052213 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 2.02690733 |
| 19 | MP0004145_abnormal_muscle_electrophysio | 1.93858111 |
| 20 | MP0003646_muscle_fatigue | 1.90426236 |
| 21 | MP0000747_muscle_weakness | 1.86814128 |
| 22 | MP0000749_muscle_degeneration | 1.86462056 |
| 23 | MP0004185_abnormal_adipocyte_glucose | 1.86224306 |
| 24 | MP0003283_abnormal_digestive_organ | 1.84323404 |
| 25 | MP0004215_abnormal_myocardial_fiber | 1.83079644 |
| 26 | MP0008961_abnormal_basal_metabolism | 1.76953157 |
| 27 | MP0005330_cardiomyopathy | 1.75281818 |
| 28 | MP0003950_abnormal_plasma_membrane | 1.73277948 |
| 29 | MP0005666_abnormal_adipose_tissue | 1.71357301 |
| 30 | MP0010234_abnormal_vibrissa_follicle | 1.70659062 |
| 31 | MP0000678_abnormal_parathyroid_gland | 1.68635302 |
| 32 | MP0002269_muscular_atrophy | 1.67490554 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.67404204 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.66475533 |
| 35 | MP0003045_fibrosis | 1.66436225 |
| 36 | MP0001348_abnormal_lacrimal_gland | 1.65540117 |
| 37 | MP0003329_amyloid_beta_deposits | 1.65060892 |
| 38 | MP0004858_abnormal_nervous_system | 1.60080168 |
| 39 | MP0005375_adipose_tissue_phenotype | 1.59739089 |
| 40 | MP0000003_abnormal_adipose_tissue | 1.59543712 |
| 41 | MP0008775_abnormal_heart_ventricle | 1.53240837 |
| 42 | MP0004272_abnormal_basement_membrane | 1.52409737 |
| 43 | MP0005023_abnormal_wound_healing | 1.52393854 |
| 44 | MP0000750_abnormal_muscle_regeneration | 1.51350531 |
| 45 | MP0000759_abnormal_skeletal_muscle | 1.45083470 |
| 46 | MP0005620_abnormal_muscle_contractility | 1.44794354 |
| 47 | MP0005670_abnormal_white_adipose | 1.44728449 |
| 48 | MP0002972_abnormal_cardiac_muscle | 1.43439931 |
| 49 | MP0002106_abnormal_muscle_physiology | 1.39311683 |
| 50 | MP0004233_abnormal_muscle_weight | 1.39174648 |
| 51 | MP0010630_abnormal_cardiac_muscle | 1.37414731 |
| 52 | MP0003942_abnormal_urinary_system | 1.37285055 |
| 53 | MP0006138_congestive_heart_failure | 1.31745356 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.30843473 |
| 55 | MP0000767_abnormal_smooth_muscle | 1.29466946 |
| 56 | MP0010030_abnormal_orbit_morphology | 1.27811470 |
| 57 | MP0002234_abnormal_pharynx_morphology | 1.25920881 |
| 58 | MP0001243_abnormal_dermal_layer | 1.24070147 |
| 59 | MP0004270_analgesia | 1.23663376 |
| 60 | MP0005385_cardiovascular_system_phenoty | 1.21540606 |
| 61 | MP0001544_abnormal_cardiovascular_syste | 1.21540606 |
| 62 | MP0005369_muscle_phenotype | 1.20430794 |
| 63 | MP0003279_aneurysm | 1.19439820 |
| 64 | MP0004085_abnormal_heartbeat | 1.18389031 |
| 65 | MP0005083_abnormal_biliary_tract | 1.17356317 |
| 66 | MP0004510_myositis | 1.16569001 |
| 67 | MP0000566_synostosis | 1.16396514 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 1.14057045 |
| 69 | MP0003137_abnormal_impulse_conducting | 1.13824205 |
| 70 | MP0003385_abnormal_body_wall | 1.12465214 |
| 71 | MP0002249_abnormal_larynx_morphology | 1.11843095 |
| 72 | MP0005508_abnormal_skeleton_morphology | 1.10893710 |
| 73 | MP0003635_abnormal_synaptic_transmissio | 1.09097570 |
| 74 | MP0001958_emphysema | 1.06804343 |
| 75 | MP0004264_abnormal_extraembryonic_tissu | 1.05713871 |
| 76 | MP0004484_altered_response_of | 1.03670781 |
| 77 | MP0004134_abnormal_chest_morphology | 1.02771607 |
| 78 | MP0001299_abnormal_eye_distance/ | 1.02179895 |
| 79 | MP0002896_abnormal_bone_mineralization | 1.01960035 |
| 80 | MP0000467_abnormal_esophagus_morphology | 1.01711870 |
| 81 | MP0005501_abnormal_skin_physiology | 0.97869633 |
| 82 | MP0000462_abnormal_digestive_system | 0.97851684 |
| 83 | MP0000733_abnormal_muscle_development | 0.97022938 |
| 84 | MP0000762_abnormal_tongue_morphology | 0.96642178 |
| 85 | MP0003091_abnormal_cell_migration | 0.96347441 |
| 86 | MP0000534_abnormal_ureter_morphology | 0.95561263 |
| 87 | MP0002108_abnormal_muscle_morphology | 0.94841746 |
| 88 | MP0009840_abnormal_foam_cell | 0.93848265 |
| 89 | MP0002078_abnormal_glucose_homeostasis | 0.91985554 |
| 90 | MP0005076_abnormal_cell_differentiation | 0.91930612 |
| 91 | MP0003941_abnormal_skin_development | 0.91291504 |
| 92 | MP0001849_ear_inflammation | 0.90435862 |
| 93 | MP0003252_abnormal_bile_duct | 0.90391141 |
| 94 | MP0000604_amyloidosis | 0.90026728 |
| 95 | MP0008569_lethality_at_weaning | 0.88743688 |
| 96 | MP0005187_abnormal_penis_morphology | 0.88218623 |
| 97 | MP0000377_abnormal_hair_follicle | 0.86827452 |
| 98 | MP0005503_abnormal_tendon_morphology | 0.86251590 |
| 99 | MP0000569_abnormal_digit_pigmentation | 0.85443620 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.84037044 |
| 101 | MP0000428_abnormal_craniofacial_morphol | 0.83704588 |
| 102 | MP0002971_abnormal_brown_adipose | 0.83133607 |
| 103 | MP0005058_abnormal_lysosome_morphology | 0.82998278 |
| 104 | MP0001879_abnormal_lymphatic_vessel | 0.82525556 |
| 105 | MP0010771_integument_phenotype | 0.81916199 |
| 106 | MP0010329_abnormal_lipoprotein_level | 0.81874421 |
| 107 | MP0002118_abnormal_lipid_homeostasis | 0.81121276 |
| 108 | MP0002796_impaired_skin_barrier | 0.80445333 |
| 109 | MP0001216_abnormal_epidermal_layer | 0.79981577 |
| 110 | MP0002060_abnormal_skin_morphology | 0.79466152 |
| 111 | MP0003959_abnormal_lean_body | 0.78154632 |
| 112 | MP0004043_abnormal_pH_regulation | 0.76525446 |
| 113 | MP0009931_abnormal_skin_appearance | 0.74684265 |
| 114 | MP0005535_abnormal_body_temperature | 0.74383672 |
| 115 | MP0005408_hypopigmentation | 0.73544040 |
| 116 | MP0001661_extended_life_span | 0.73208769 |
| 117 | MP0002925_abnormal_cardiovascular_devel | 0.72552744 |
| 118 | MP0010678_abnormal_skin_adnexa | 0.72063985 |
| 119 | MP0003172_abnormal_lysosome_physiology | 0.70461748 |
| 120 | MP0001765_abnormal_ion_homeostasis | 0.70084157 |
| 121 | MP0001614_abnormal_blood_vessel | 0.69701385 |
| 122 | MP0001440_abnormal_grooming_behavior | 0.68820148 |
| 123 | MP0002089_abnormal_postnatal_growth/wei | 0.68375489 |
| 124 | MP0009384_cardiac_valve_regurgitation | 0.68216155 |
| 125 | MP0002128_abnormal_blood_circulation | 0.67687198 |
| 126 | MP0003115_abnormal_respiratory_system | 0.67603612 |
| 127 | MP0005448_abnormal_energy_balance | 0.66933790 |
| 128 | MP0001944_abnormal_pancreas_morphology | 0.66243675 |
| 129 | MP0000266_abnormal_heart_morphology | 0.66233008 |
| 130 | MP0003879_abnormal_hair_cell | 0.65707943 |
| 131 | MP0009046_muscle_twitch | 0.64584099 |
| 132 | MP0002295_abnormal_pulmonary_circulatio | 0.64522039 |
| 133 | MP0002063_abnormal_learning/memory/cond | 0.64421752 |
| 134 | MP0002098_abnormal_vibrissa_morphology | 0.64315630 |
| 135 | MP0005595_abnormal_vascular_smooth | 0.63832564 |
| 136 | MP0002168_other_aberrant_phenotype | 0.63507227 |
| 137 | MP0002090_abnormal_vision | 0.62746395 |
| 138 | MP0005365_abnormal_bile_salt | 0.62691934 |
| 139 | MP0003633_abnormal_nervous_system | 0.62680885 |
| 140 | MP0002116_abnormal_craniofacial_bone | 0.62523123 |
| 141 | MP0004811_abnormal_neuron_physiology | 0.62341404 |
| 142 | MP0003191_abnormal_cellular_cholesterol | 0.62271756 |
| 143 | MP0000432_abnormal_head_morphology | 0.61186516 |
| 144 | MP0010368_abnormal_lymphatic_system | 0.61142478 |
| 145 | MP0000579_abnormal_nail_morphology | 0.61031366 |
| 146 | MP0000383_abnormal_hair_follicle | 0.60303349 |
| 147 | MP0003935_abnormal_craniofacial_develop | 0.60006994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 3.81372163 |
| 2 | Hyporeflexia of lower limbs (HP:0002600) | 3.75537769 |
| 3 | Right ventricular cardiomyopathy (HP:0011663) | 3.47182447 |
| 4 | Difficulty running (HP:0009046) | 3.42110607 |
| 5 | Cerebral aneurysm (HP:0004944) | 3.42075160 |
| 6 | Increased connective tissue (HP:0009025) | 3.29825324 |
| 7 | Exercise-induced myalgia (HP:0003738) | 3.26506867 |
| 8 | Muscle fiber splitting (HP:0003555) | 3.20573245 |
| 9 | Bundle branch block (HP:0011710) | 3.16801752 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 3.11097838 |
| 11 | Increased variability in muscle fiber diameter (HP:0003557) | 3.02789622 |
| 12 | Asymmetric septal hypertrophy (HP:0001670) | 2.97783271 |
| 13 | Vascular tortuosity (HP:0004948) | 2.96264532 |
| 14 | Difficulty climbing stairs (HP:0003551) | 2.95009755 |
| 15 | Arterial tortuosity (HP:0005116) | 2.90399352 |
| 16 | Protrusio acetabuli (HP:0003179) | 2.89118951 |
| 17 | Exercise-induced muscle cramps (HP:0003710) | 2.88663531 |
| 18 | Abnormality of dentin (HP:0010299) | 2.84291227 |
| 19 | Ventricular tachycardia (HP:0004756) | 2.80326292 |
| 20 | Premature rupture of membranes (HP:0001788) | 2.79277354 |
| 21 | Soft skin (HP:0000977) | 2.78910265 |
| 22 | Ventricular fibrillation (HP:0001663) | 2.75455759 |
| 23 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.75267403 |
| 24 | Distal upper limb amyotrophy (HP:0007149) | 2.73442144 |
| 25 | Upper limb amyotrophy (HP:0009129) | 2.73442144 |
| 26 | Broad metatarsal (HP:0001783) | 2.70784740 |
| 27 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.58046753 |
| 28 | Wormian bones (HP:0002645) | 2.55332525 |
| 29 | Myoglobinuria (HP:0002913) | 2.54681285 |
| 30 | Ankyloglossia (HP:0010296) | 2.50750017 |
| 31 | Biconcave vertebral bodies (HP:0004586) | 2.42746444 |
| 32 | Aneurysm (HP:0002617) | 2.41959156 |
| 33 | Blue sclerae (HP:0000592) | 2.41759545 |
| 34 | Syncope (HP:0001279) | 2.40378016 |
| 35 | Disproportionate tall stature (HP:0001519) | 2.37919746 |
| 36 | Abnormality of the calf musculature (HP:0001430) | 2.37773650 |
| 37 | Ulnar bowing (HP:0003031) | 2.37065126 |
| 38 | Shallow orbits (HP:0000586) | 2.37039434 |
| 39 | Follicular hyperkeratosis (HP:0007502) | 2.36163050 |
| 40 | Neonatal short-limb short stature (HP:0008921) | 2.35225596 |
| 41 | Atelectasis (HP:0100750) | 2.34961344 |
| 42 | Calf muscle hypertrophy (HP:0008981) | 2.34378616 |
| 43 | Hand muscle atrophy (HP:0009130) | 2.33404614 |
| 44 | Ventricular arrhythmia (HP:0004308) | 2.32900271 |
| 45 | Atrial fibrillation (HP:0005110) | 2.32096346 |
| 46 | Abnormality of the lower motor neuron (HP:0002366) | 2.31757389 |
| 47 | Flat cornea (HP:0007720) | 2.30136303 |
| 48 | Round ear (HP:0100830) | 2.27585085 |
| 49 | Prolonged QT interval (HP:0001657) | 2.27176829 |
| 50 | Obstructive sleep apnea (HP:0002870) | 2.26549447 |
| 51 | Bladder diverticulum (HP:0000015) | 2.25216516 |
| 52 | Atrophic scars (HP:0001075) | 2.24997882 |
| 53 | Ankle contracture (HP:0006466) | 2.24501146 |
| 54 | Myotonia (HP:0002486) | 2.24212186 |
| 55 | Broad face (HP:0000283) | 2.24061685 |
| 56 | EMG: myopathic abnormalities (HP:0003458) | 2.23986976 |
| 57 | Atrioventricular block (HP:0001678) | 2.23728587 |
| 58 | Hyperextensible skin (HP:0000974) | 2.23248538 |
| 59 | Lymphangioma (HP:0100764) | 2.22567624 |
| 60 | Dysmetric saccades (HP:0000641) | 2.22281706 |
| 61 | Primary atrial arrhythmia (HP:0001692) | 2.22250284 |
| 62 | Venous abnormality (HP:0002624) | 2.21855195 |
| 63 | Hyperacusis (HP:0010780) | 2.20934115 |
| 64 | Genu recurvatum (HP:0002816) | 2.20515902 |
| 65 | Joint laxity (HP:0001388) | 2.19336640 |
| 66 | Overgrowth (HP:0001548) | 2.16181678 |
| 67 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.15020795 |
| 68 | J-shaped sella turcica (HP:0002680) | 2.14978118 |
| 69 | Rapidly progressive (HP:0003678) | 2.14954645 |
| 70 | Long toe (HP:0010511) | 2.14510945 |
| 71 | Flat acetabular roof (HP:0003180) | 2.12572459 |
| 72 | Scapular winging (HP:0003691) | 2.12376263 |
| 73 | Heart block (HP:0012722) | 2.12043502 |
| 74 | Ketoacidosis (HP:0001993) | 2.11588444 |
| 75 | Abnormality of the acetabulum (HP:0003170) | 2.11567319 |
| 76 | Abnormal atrioventricular conduction (HP:0005150) | 2.11438983 |
| 77 | Asymmetry of the thorax (HP:0001555) | 2.11220959 |
| 78 | Venous insufficiency (HP:0005293) | 2.10316189 |
| 79 | Achilles tendon contracture (HP:0001771) | 2.09561439 |
| 80 | Abnormality of oral frenula (HP:0000190) | 2.09313782 |
| 81 | Vertebral compression fractures (HP:0002953) | 2.08704449 |
| 82 | Breech presentation (HP:0001623) | 2.08090921 |
| 83 | Mitral valve prolapse (HP:0001634) | 2.06973589 |
| 84 | Supraventricular arrhythmia (HP:0005115) | 2.06711897 |
| 85 | Hyperthyroidism (HP:0000836) | 2.06508735 |
| 86 | Peritonitis (HP:0002586) | 2.05709752 |
| 87 | Mitral regurgitation (HP:0001653) | 2.05172062 |
| 88 | Aortic aneurysm (HP:0004942) | 2.04764848 |
| 89 | Subaortic stenosis (HP:0001682) | 2.03325645 |
| 90 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.03325645 |
| 91 | Truncus arteriosus (HP:0001660) | 2.03078959 |
| 92 | Advanced eruption of teeth (HP:0006288) | 2.03022171 |
| 93 | Supraventricular tachycardia (HP:0004755) | 2.02303873 |
| 94 | Abnormal delivery (HP:0001787) | 2.02009053 |
| 95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.00307716 |
| 96 | Hamartoma of the eye (HP:0010568) | 1.99411712 |
| 97 | Abnormality of the Achilles tendon (HP:0005109) | 1.98348065 |
| 98 | Short nail (HP:0001799) | 1.98178768 |
| 99 | Fragile skin (HP:0001030) | 1.98143699 |
| 100 | Ulnar deviation of the wrist (HP:0003049) | 1.97722773 |
| 101 | Distal lower limb amyotrophy (HP:0008944) | 1.97396432 |
| 102 | Cerebral inclusion bodies (HP:0100314) | 1.97257562 |
| 103 | Lower limb amyotrophy (HP:0007210) | 1.97255731 |
| 104 | Supranuclear gaze palsy (HP:0000605) | 1.95450920 |
| 105 | Insomnia (HP:0100785) | 1.94608490 |
| 106 | Aortic dissection (HP:0002647) | 1.94101178 |
| 107 | Global brain atrophy (HP:0002283) | 1.94096959 |
| 108 | Mitral stenosis (HP:0001718) | 1.93956384 |
| 109 | Renal duplication (HP:0000075) | 1.93909057 |
| 110 | Aortic regurgitation (HP:0001659) | 1.93886966 |
| 111 | Lipoatrophy (HP:0100578) | 1.93580647 |
| 112 | Slender build (HP:0001533) | 1.92640800 |
| 113 | EMG: neuropathic changes (HP:0003445) | 1.92441688 |
| 114 | Elbow flexion contracture (HP:0002987) | 1.92386641 |
| 115 | Hypercortisolism (HP:0001578) | 1.92219144 |
| 116 | Visual hallucinations (HP:0002367) | 1.91196980 |
| 117 | Bell-shaped thorax (HP:0001591) | 1.88411069 |
| 118 | Spinal rigidity (HP:0003306) | 1.87119891 |
| 119 | Frequent falls (HP:0002359) | 1.85750543 |
| 120 | Dilatation of the ascending aorta (HP:0005111) | 1.84874745 |
| 121 | Patellar dislocation (HP:0002999) | 1.83696731 |
| 122 | Natal tooth (HP:0000695) | 1.82740380 |
| 123 | Nonimmune hydrops fetalis (HP:0001790) | 1.82444487 |
| 124 | Osteoarthritis (HP:0002758) | 1.81864860 |
| 125 | Hypoplastic ischia (HP:0003175) | 1.81823295 |
| 126 | Abnormality of the tricuspid valve (HP:0001702) | 1.81131116 |
| 127 | Persistence of primary teeth (HP:0006335) | 1.80699819 |
| 128 | Macroorchidism (HP:0000053) | 1.78200032 |
| 129 | Distal lower limb muscle weakness (HP:0009053) | 1.78114793 |
| 130 | Termporal pattern (HP:0011008) | 1.78016969 |
| 131 | Insidious onset (HP:0003587) | 1.78016969 |
| 132 | Limb-girdle muscle atrophy (HP:0003797) | 1.77864369 |
| 133 | Bowel diverticulosis (HP:0005222) | 1.77773138 |
| 134 | Skin nodule (HP:0200036) | 1.76354671 |
| 135 | Striae distensae (HP:0001065) | 1.74173952 |
| 136 | Stridor (HP:0010307) | 1.72940434 |
| 137 | Action tremor (HP:0002345) | 1.72687721 |
| 138 | Enlarged penis (HP:0000040) | 1.72395943 |
| 139 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.72229264 |
| 140 | Polycythemia (HP:0001901) | 1.71793890 |
| 141 | Deformed sella turcica (HP:0002681) | 1.71487729 |
| 142 | Wide anterior fontanel (HP:0000260) | 1.71185752 |
| 143 | Abnormality of the ischium (HP:0003174) | 1.70855474 |
| 144 | Cervical subluxation (HP:0003308) | 1.70452008 |
| 145 | Turricephaly (HP:0000262) | 1.69438481 |
| 146 | Osteolytic defects of the hand bones (HP:0009699) | 1.69345870 |
| 147 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.69345870 |
| 148 | Resting tremor (HP:0002322) | 1.69253154 |
| 149 | Buphthalmos (HP:0000557) | 1.69245177 |
| 150 | Abnormality of nail color (HP:0100643) | 1.68778817 |
| 151 | Sparse lateral eyebrow (HP:0005338) | 1.68728512 |
| 152 | Reticulocytosis (HP:0001923) | 1.68519891 |
| 153 | Congenital glaucoma (HP:0001087) | 1.67048789 |
| 154 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.66347188 |
| 155 | Hyperglycemia (HP:0003074) | 1.65536154 |
| 156 | Ectopia lentis (HP:0001083) | 1.65378326 |
| 157 | Abnormal EKG (HP:0003115) | 1.65339593 |
| 158 | Thin bony cortex (HP:0002753) | 1.63400487 |
| 159 | Vertebral arch anomaly (HP:0008438) | 1.63040121 |
| 160 | Sudden cardiac death (HP:0001645) | 1.62109361 |
| 161 | Premature skin wrinkling (HP:0100678) | 1.60690614 |
| 162 | Neoplasm of the heart (HP:0100544) | 1.59983392 |
| 163 | Bronchomalacia (HP:0002780) | 1.59672746 |
| 164 | Renovascular hypertension (HP:0100817) | 1.57995701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.36316554 |
| 2 | TTN | 3.20094529 |
| 3 | PKN2 | 2.78394336 |
| 4 | LMTK2 | 2.69941445 |
| 5 | ERN1 | 2.34079491 |
| 6 | RIPK1 | 2.27464047 |
| 7 | EPHA2 | 2.10127421 |
| 8 | PDGFRA | 1.99279397 |
| 9 | SIK1 | 1.96693837 |
| 10 | PRKD3 | 1.93797898 |
| 11 | MAP3K9 | 1.93115038 |
| 12 | CDK12 | 1.83201099 |
| 13 | DMPK | 1.82288578 |
| 14 | MST1R | 1.72820312 |
| 15 | EEF2K | 1.69411763 |
| 16 | PTK6 | 1.68172746 |
| 17 | PHKG2 | 1.64862725 |
| 18 | PHKG1 | 1.64862725 |
| 19 | PDK3 | 1.64531701 |
| 20 | PDK4 | 1.64531701 |
| 21 | MAP3K6 | 1.52100753 |
| 22 | NTRK1 | 1.49786023 |
| 23 | CAMK1G | 1.47825911 |
| 24 | FER | 1.41936180 |
| 25 | MET | 1.40358677 |
| 26 | DDR2 | 1.38813080 |
| 27 | RET | 1.37571081 |
| 28 | KSR2 | 1.35304592 |
| 29 | PAK6 | 1.34207045 |
| 30 | NTRK3 | 1.30345251 |
| 31 | MAP3K2 | 1.30239605 |
| 32 | CAMKK1 | 1.28386744 |
| 33 | AKT3 | 1.23061595 |
| 34 | LATS2 | 1.22484226 |
| 35 | PAK3 | 1.22110729 |
| 36 | CAMK1D | 1.20044505 |
| 37 | PRKCH | 1.18542694 |
| 38 | EPHB1 | 1.16364269 |
| 39 | LATS1 | 1.16307291 |
| 40 | STK38 | 1.16143217 |
| 41 | ICK | 1.15527749 |
| 42 | IRAK3 | 1.13120846 |
| 43 | SMG1 | 1.12770659 |
| 44 | MAP3K7 | 1.12215911 |
| 45 | PTK2B | 1.09507894 |
| 46 | PTK2 | 1.08677673 |
| 47 | TAOK1 | 1.04393299 |
| 48 | PDGFRB | 1.01788020 |
| 49 | PRPF4B | 1.00934433 |
| 50 | MAP3K10 | 1.00162392 |
| 51 | TYRO3 | 0.97887599 |
| 52 | PRKD1 | 0.96954888 |
| 53 | SCYL2 | 0.90176729 |
| 54 | WNK1 | 0.89546394 |
| 55 | CDC42BPA | 0.88602844 |
| 56 | MAP3K4 | 0.88301213 |
| 57 | WNK4 | 0.88025340 |
| 58 | DAPK2 | 0.87019897 |
| 59 | PAK4 | 0.85270707 |
| 60 | MTOR | 0.83219053 |
| 61 | FGFR4 | 0.83117349 |
| 62 | MARK2 | 0.83084087 |
| 63 | PIK3CG | 0.82709198 |
| 64 | PDPK1 | 0.79698815 |
| 65 | TESK1 | 0.79275791 |
| 66 | RPS6KB2 | 0.79069482 |
| 67 | SIK2 | 0.78909468 |
| 68 | BMX | 0.78909325 |
| 69 | PDK2 | 0.77502324 |
| 70 | MAP2K4 | 0.77340794 |
| 71 | MAP3K1 | 0.76361775 |
| 72 | FRK | 0.76013417 |
| 73 | TAOK3 | 0.75771844 |
| 74 | ROCK1 | 0.74597031 |
| 75 | NEK9 | 0.74023831 |
| 76 | FGFR2 | 0.73919634 |
| 77 | CLK1 | 0.72146958 |
| 78 | JAK1 | 0.71556052 |
| 79 | PRKAA1 | 0.69153582 |
| 80 | INSRR | 0.68638972 |
| 81 | NEK1 | 0.67940706 |
| 82 | SGK3 | 0.66505136 |
| 83 | PAK2 | 0.66394682 |
| 84 | LRRK2 | 0.66092771 |
| 85 | EPHA3 | 0.65941479 |
| 86 | OBSCN | 0.65567510 |
| 87 | RPS6KA2 | 0.64366724 |
| 88 | CDK5 | 0.64073457 |
| 89 | ALK | 0.62203287 |
| 90 | MYLK | 0.61980233 |
| 91 | EPHB2 | 0.61855588 |
| 92 | PDK1 | 0.61389192 |
| 93 | MAP2K1 | 0.60717486 |
| 94 | MINK1 | 0.60434471 |
| 95 | MAPKAPK3 | 0.59994829 |
| 96 | EPHA4 | 0.58911997 |
| 97 | KSR1 | 0.56934495 |
| 98 | PIK3CA | 0.56908052 |
| 99 | BCKDK | 0.55751679 |
| 100 | STK11 | 0.55498267 |
| 101 | MAPK12 | 0.55199456 |
| 102 | STK3 | 0.54871836 |
| 103 | ILK | 0.53615053 |
| 104 | NTRK2 | 0.52935797 |
| 105 | MAP2K3 | 0.52690453 |
| 106 | HIPK2 | 0.51502003 |
| 107 | MAPK15 | 0.50687522 |
| 108 | MAP2K2 | 0.50406999 |
| 109 | MAPK11 | 0.49770548 |
| 110 | RAF1 | 0.49709895 |
| 111 | JAK2 | 0.49706242 |
| 112 | MAP3K3 | 0.49382163 |
| 113 | WNK3 | 0.48570752 |
| 114 | MAP3K13 | 0.47885918 |
| 115 | NME1 | 0.47747699 |
| 116 | RIPK4 | 0.47320172 |
| 117 | CAMKK2 | 0.45307360 |
| 118 | ROCK2 | 0.44478164 |
| 119 | PRKAA2 | 0.43848299 |
| 120 | TRPM7 | 0.43689823 |
| 121 | MAP2K6 | 0.43396696 |
| 122 | FGFR3 | 0.43349147 |
| 123 | UHMK1 | 0.43258495 |
| 124 | AKT2 | 0.42783846 |
| 125 | PRKD2 | 0.42690195 |
| 126 | PRKG2 | 0.42400873 |
| 127 | RPS6KL1 | 0.41803588 |
| 128 | RPS6KC1 | 0.41803588 |
| 129 | NEK2 | 0.40003943 |
| 130 | CAMK2D | 0.39589801 |
| 131 | MARK1 | 0.39410278 |
| 132 | MUSK | 0.38615155 |
| 133 | MAPK10 | 0.38078335 |
| 134 | GRK5 | 0.36497006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.92617716 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.81725516 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 1.80222965 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.77511080 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.56901310 |
| 6 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.56796359 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.56041191 |
| 8 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.45912285 |
| 9 | Insulin secretion_Homo sapiens_hsa04911 | 1.45078877 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42683491 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.40610063 |
| 12 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.38391194 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.34379301 |
| 14 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.32019708 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.31497210 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.30030822 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.29563433 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.27899475 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.27474188 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.27125404 |
| 21 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.27074434 |
| 22 | Thyroid cancer_Homo sapiens_hsa05216 | 1.25244524 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.25081175 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.22681137 |
| 25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.18252854 |
| 26 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14234545 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.14215400 |
| 28 | Focal adhesion_Homo sapiens_hsa04510 | 1.14092326 |
| 29 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13888680 |
| 30 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.13539627 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.13074591 |
| 32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11859869 |
| 33 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.11536786 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.11318109 |
| 35 | Long-term potentiation_Homo sapiens_hsa04720 | 1.09528273 |
| 36 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.08847893 |
| 37 | Circadian entrainment_Homo sapiens_hsa04713 | 1.08093397 |
| 38 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.08026478 |
| 39 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.07927867 |
| 40 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.07298835 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.06692008 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06511997 |
| 43 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.05399123 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.04983821 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.04128631 |
| 46 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.03965215 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 1.03426486 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 1.03387741 |
| 49 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03304653 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.03112053 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02410770 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02240419 |
| 53 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.99344931 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98881311 |
| 55 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.98591915 |
| 56 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.96631866 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.95369031 |
| 58 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.93875119 |
| 59 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.93529342 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92673478 |
| 61 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.92289429 |
| 62 | Olfactory transduction_Homo sapiens_hsa04740 | 0.91841435 |
| 63 | Prostate cancer_Homo sapiens_hsa05215 | 0.90020351 |
| 64 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.89606331 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.87463686 |
| 66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.86955186 |
| 67 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86882806 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.86143276 |
| 69 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.86037392 |
| 70 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.85297087 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84554937 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.84386736 |
| 73 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.84276980 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84239751 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83312568 |
| 76 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81959437 |
| 77 | Cocaine addiction_Homo sapiens_hsa05030 | 0.81332080 |
| 78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.81058821 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.80789651 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79586218 |
| 81 | Gap junction_Homo sapiens_hsa04540 | 0.79530053 |
| 82 | GABAergic synapse_Homo sapiens_hsa04727 | 0.79431813 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.79288985 |
| 84 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.78600807 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76816681 |
| 86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76557362 |
| 87 | Axon guidance_Homo sapiens_hsa04360 | 0.75466319 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75034536 |
| 89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74358695 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73396532 |
| 91 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.72022401 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71091173 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70891391 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70202123 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69504833 |
| 96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.69026300 |
| 97 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68937525 |
| 98 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68393417 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67982108 |
| 100 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67503173 |
| 101 | Melanoma_Homo sapiens_hsa05218 | 0.67483263 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67054832 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66114500 |
| 104 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.64693838 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64279102 |
| 106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64098976 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64024096 |
| 108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64013564 |
| 109 | ABC transporters_Homo sapiens_hsa02010 | 0.63840829 |
| 110 | Morphine addiction_Homo sapiens_hsa05032 | 0.63557431 |
| 111 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.63438327 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62889560 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62858661 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62809566 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62433469 |
| 116 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61778495 |
| 117 | Melanogenesis_Homo sapiens_hsa04916 | 0.61547556 |
| 118 | Platelet activation_Homo sapiens_hsa04611 | 0.60318045 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59632835 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59051435 |
| 121 | Adherens junction_Homo sapiens_hsa04520 | 0.57663380 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.57531358 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56849660 |
| 124 | Tight junction_Homo sapiens_hsa04530 | 0.56342795 |
| 125 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.56003634 |
| 126 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55806693 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55356248 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54816107 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54134577 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54081928 |
| 131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53997777 |
| 132 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53603838 |
| 133 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.53211463 |
| 134 | Taste transduction_Homo sapiens_hsa04742 | 0.52084185 |
| 135 | Long-term depression_Homo sapiens_hsa04730 | 0.52019503 |
| 136 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.51762619 |
| 137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50911249 |
| 138 | Bladder cancer_Homo sapiens_hsa05219 | 0.50873873 |

